Long pages

Showing below up to 50 results in range #351 to #400.

351. (hist) ‎Peripheral artery disease ‎[5,983 bytes]
352. (hist) ‎53. Forms, general pathophysiology and consequences of anaemia ‎[5,959 bytes]
353. (hist) ‎35. Cold-defense and cold-induced disorders ‎[5,954 bytes]
354. (hist) ‎3B. Treatment of the acute stroke (+ evaluation) ‎[5,950 bytes]
355. (hist) ‎20. Calcium channel blockers ‎[5,934 bytes]
356. (hist) ‎16. General characterisation of amyloidosis. Physico-chemical, ultrastructural and histochemical nature of amyloid. Types of amyloid ‎[5,927 bytes]
357. (hist) ‎31. T and NK cell lymphomas ‎[5,925 bytes]
358. (hist) ‎41. Nonglial central nervous system tumors ‎[5,922 bytes]
359. (hist) ‎Endometrial cancer ‎[5,903 bytes]
360. (hist) ‎58. Hyperthyroidism. Specialities in the elderly ‎[5,886 bytes]
361. (hist) ‎15. Pathomechanism and clinicopathological forms of stone formation ‎[5,864 bytes]
362. (hist) ‎77. Metabolic acidosis. Causes, compensation, consequences ‎[5,855 bytes]
363. (hist) ‎A0. Good-to-know gynaecology stuff which isn’t covered in other topics ‎[5,844 bytes]
364. (hist) ‎62. Adrenogenital syndrome. Disorders of gonadal hormones ‎[5,841 bytes]
365. (hist) ‎36. Forms and consequences of paroxysmal tachycardia ‎[5,840 bytes]
366. (hist) ‎80. Anthelminthic drugs ‎[5,830 bytes]
367. (hist) ‎Intravenous anaesthetics ‎[5,820 bytes]
368. (hist) ‎55. Inflammations, tumourlike lesions and tumours of the cervix. Carcinoma of the cervix (pathogenesis, pathomorphology, screening) ‎[5,809 bytes]
369. (hist) ‎Circulatory shock ‎[5,785 bytes]
370. (hist) ‎50. Prostatitides. Hyperplasia of the prostate, complications ‎[5,783 bytes]
371. (hist) ‎9. Assessment of nutritional status, nutritional screening ‎[5,772 bytes]
372. (hist) ‎13. Effector functions of antibodies ‎[5,766 bytes]
373. (hist) ‎72. Acute renal failure. Occurrence, general features – extrarenal uremia. Prerenal azotemia. Postrenal failure ‎[5,751 bytes]
374. (hist) ‎18. Suppression of the immune response ‎[5,750 bytes]
375. (hist) ‎67. Parathyroid hormone, calcitonin and vitamin D, drugs used to treat osteoporosis ‎[5,746 bytes]
376. (hist) ‎15. Effector mechanisms of cell-mediated immune response ‎[5,742 bytes]
377. (hist) ‎59. Drug abuse and dependence. Psychomotor stimulants, psychedelics, cannabis ‎[5,730 bytes]
378. (hist) ‎26. Fat-soluble vitamins ‎[5,724 bytes]
379. (hist) ‎69. Hypocalcemia, hypercalcemia ‎[5,723 bytes]
380. (hist) ‎ST-elevation myocardial infarction ‎[5,720 bytes]
381. (hist) ‎76. Antifungal drugs ‎[5,717 bytes]
382. (hist) ‎Renal replacement therapy ‎[5,714 bytes]
383. (hist) ‎53. O2 and CO2 transport in the body ‎[5,710 bytes]
384. (hist) ‎59. Hypothyroidism. Specialities in the elderly ‎[5,706 bytes]
385. (hist) ‎75. Regulation of renal blood flow and pressure. Renin-angiotensin system ‎[5,703 bytes]
386. (hist) ‎66. Glucocorticoid hyperfunctional states ‎[5,694 bytes]
387. (hist) ‎66. Pleural and mediastinal disorders ‎[5,693 bytes]
388. (hist) ‎9. Central and peripheral T-cell differentiation. T-cell development in the thymus. ‎[5,680 bytes]
389. (hist) ‎48. Microbial carcinogenesis. RNA and DNA viruses. Helicobacter pylori ‎[5,676 bytes]
390. (hist) ‎Haematuria ‎[5,609 bytes]
391. (hist) ‎Pacemaker ‎[5,589 bytes]
392. (hist) ‎50. Grading and staging. Laboratory diagnosis of cancer ‎[5,583 bytes]
393. (hist) ‎Hyperparathyroidism ‎[5,574 bytes]
394. (hist) ‎30. Central and peripheral factors in the regulation of food intake and body weight. Disorders ‎[5,543 bytes]
395. (hist) ‎45. Diabetic ketoacidosis (DKA) and ketoacidotic coma ‎[5,536 bytes]
396. (hist) ‎B14. Diagnosis and pathomechanism of hydramnios and oligohydramnios ‎[5,525 bytes]
397. (hist) ‎Central nervous system tumour ‎[5,504 bytes]
398. (hist) ‎28. Partial starvation, accelerated forms of energetic insufficiency – anorexia nervosa. Refeeding ‎[5,501 bytes]
399. (hist) ‎61. Disseminated intravascular coagulation (DIC) ‎[5,490 bytes]
400. (hist) ‎Hypernatraemia ‎[5,485 bytes]